Treatment linked to continued stabilization of motor function in adults with SMA

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Jun 15 / Springer Healthcare

Treatment linked to continued stabilization of motor function in adults with SMA

Neuroscience Spinal Muscular Atrophy CURE-SMA-2022

Description

Tina Duong talks through the findings of a real-world follow-up study demonstrating that treatment with nusinersen is associated with continued stabilization of motor function over 2–3 years among adult patients with spinal muscular atrophy.

Follow us here

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.